Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, April 23, 2024 | Back issues
Courthouse News Service Courthouse News Service

Class Action Against AstraZeneca Dismissed

MANHATTAN (CN) - A federal judge has dismissed a shareholders' class action that claims AstraZeneca and four of its officers and board members manipulated the price of its stock. The complaint claimed the company misrepresented the prospects of its heart drug, Exanta, from April 2003 to September 2004.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...